Literature DB >> 31196209

Estimation and application of population attributable fraction in ecological studies.

Cheng-Kuan Lin1, Szu-Ta Chen2.   

Abstract

Estimation of population attributable fraction (PAF) requires unbiased relative risk (RR) by using either Levin's or Miettinen's formula, on which decision depends on the available exposure information in reference group, not the types of studies. For ecological studies and studies with aggregated outcomes, once having unbiased RRs, Levin's and Miettinen's formulae would provide identical PAF estimates. PAF could also be applied to compare relative burdens of disease between countries across time, which is an additional information in consideration of country-level policies.

Entities:  

Keywords:  Ecological study; Population attributable fraction

Mesh:

Year:  2019        PMID: 31196209      PMCID: PMC6567453          DOI: 10.1186/s12940-019-0492-4

Source DB:  PubMed          Journal:  Environ Health        ISSN: 1476-069X            Impact factor:   5.984


To the Editor Population attributable fraction (PAF) is widely used to measure the disease burden attributable to a given risk factor. Concerns on improper estimation of PAF in ecological studies are raised [1] in consideration of potential ecological bias. However, if unbiased relative risks (RR) are available, estimation of PAF from ecological studies is feasible, either by using Levin’s or Miettinen’s formula. In a recent published ecological study [2], for example, the PAF is referred to the proportion of subjects with lung cancer that would have not occurred if coal-fired power plants (the exposure of interest) were absent counterfactually, assuming the same probability of getting lung cancer in the exposed and unexposed groups with the remaining risk factors. Considering a randomly selected country i, the numbers of subjects with and without lung cancer in the exposed and unexposed groups can be presented as Table 1.
Table 1

Numbers of subjects with and without disease in exposed and non-exposed groups

With disease (Cases, lung cancer)Without disease (reference)Total
Exposed groupabX
Unexposed groupcdY
Numbers of subjects with and without disease in exposed and non-exposed groups where O = observed numbers of subjects with lung cancer; E = expected numbers of subjects with lung cancer had everyone not been exposed in country i. PAF could also be expressed as either Levin’s or Miettinen’s formula, respectively. (Levin’s formula) [3]. (Miettinen’s formula) [4]. where. , the proportion of subjects being exposed in the population; , relative risk of lung cancer comparing the subjects among exposed and unexposed groups; , the proportion of exposed cases among lung cancer subjects. Mathematically, the PAF calculated by using Levin’s formula would be identical to that from Miettinen’s formula, regardless whether P = P = 1 or not, as proved below. Levin’s formula: Miettinen’s formula: One major reason that researchers commonly use Levin’s formula to estimate PAF in case-control studies and use Miettinen’s formula in cohort studies, respectively, is because of data availability. In case-control studies, researchers have sufficient information of the four cells in Table 1. Whereas in cohort studies and studies with aggregated data (e.g., standardized incidence ratio (SIR) and standardized mortality ratio (SMR) studies), most researchers do not have the exposure information among subjects without diseases (i.e. b and d cells in Table 1), and thus P is not available. Once having sufficient information in observational studies, the use of either Miettinen’s or Levin’s formula would yield an identical PAF estimate. Furthermore, although both requiring unbiased RRs for estimation of PAF in Levin’s and Miettinen’s formulae, methods to obtain the unbiased RRs are different according to study types, such as using confounding adjustment (mostly from regression models) in case-control studies and stratification (e.g., SMR stratified by age and sex) in observational studies [5]. Theoretically, unbiased RRs from either fully adjustment (i.e., no residual confounding) or fully stratification (i.e., no residual confounding within stratum) should be identical and feasible for PAF estimation [6]. World Health Organization and Institute for Health Metrics and Evaluation applied a hybrid method, which age- and sex-stratified RRs were retrieved by prior meta-analysis or regression models, and summarized in standardized populations to estimate PAFs (i.e., global burden of diseases) [7]. Given fully adjusted and unbiased estimation, RRs derived from ecological studies and other studies with aggregated outcomes would be as valid as those from case-control studies, and therefore, are legit for PAF estimation. Lastly, PAF estimates could be interpreted as relative strength of a relationship between exposure and disease, regardless of the nature of association or causation [8], and subsequently be applied to compare relative burden of diseases across countries/populations. In Lin’s study [2], for example, relative burden of lung cancer between countries across time contribute valuable information in consideration of country-level policies. In conclusion, valid PAF estimation could be achieved from both Levin’s and Miettinen’s formulae with sufficient information in different types of studies with unbiased RR estimation, regardless stratification or adjustment. Comparison of PAFs between countries across time might provide additional information, along with the point estimate per se.
  6 in total

1.  The occurrence of lung cancer in man.

Authors:  M L LEVIN
Journal:  Acta Unio Int Contra Cancrum       Date:  1953

2.  Use and misuse of population attributable fractions.

Authors:  B Rockhill; B Newman; C Weinberg
Journal:  Am J Public Health       Date:  1998-01       Impact factor: 9.308

3.  Proportion of disease caused or prevented by a given exposure, trait or intervention.

Authors:  O S Miettinen
Journal:  Am J Epidemiol       Date:  1974-05       Impact factor: 4.897

Review 4.  Ecologic studies in epidemiology: concepts, principles, and methods.

Authors:  H Morgenstern
Journal:  Annu Rev Public Health       Date:  1995       Impact factor: 21.981

Review 5.  Estimating population attributable fractions to quantify the health burden of obesity.

Authors:  Katherine M Flegal; Orestis A Panagiotou; Barry I Graubard
Journal:  Ann Epidemiol       Date:  2014-11-13       Impact factor: 3.797

6.  A global perspective on coal-fired power plants and burden of lung cancer.

Authors:  Cheng-Kuan Lin; Ro-Ting Lin; Tom Chen; Corwin Zigler; Yaguang Wei; David C Christiani
Journal:  Environ Health       Date:  2019-01-28       Impact factor: 5.984

  6 in total
  5 in total

1.  Burden of Coronary Heart Disease and Cancer from Dietary Exposure to Inorganic Arsenic in Adults in China, 2016.

Authors:  Jialin Liu; Wenjing Song; Yiling Li; Yibaina Wang; Yuan Cui; Jiao Huang; Qi Wang; Sheng Wei
Journal:  Ann Glob Health       Date:  2022-04-28       Impact factor: 3.640

2.  First-trimester exposure to benzodiazepines and risk of congenital malformations in offspring: A population-based cohort study in South Korea.

Authors:  Yunha Noh; Hyesung Lee; Ahhyung Choi; Jun Soo Kwon; Seung-Ah Choe; Jungmi Chae; Dong-Sook Kim; Ju-Young Shin
Journal:  PLoS Med       Date:  2022-03-02       Impact factor: 11.069

3.  A comparison of risk factors for cryptosporidiosis and non-cryptosporidiosis diarrhoea: A case-case-control study in Ethiopian children.

Authors:  Øystein Haarklau Johansen; Alemseged Abdissa; Mike Zangenberg; Zeleke Mekonnen; Beza Eshetu; Bizuwarek Sharew; Sabrina Moyo; Halvor Sommerfelt; Nina Langeland; Lucy J Robertson; Kurt Hanevik
Journal:  PLoS Negl Trop Dis       Date:  2022-06-06

4.  Trends in State Policy Support for Sexual Minorities and HIV-Related Outcomes Among Men Who Have Sex With Men in the United States, 2008-2014.

Authors:  Mark L Hatzenbuehler; Sarah McKetta; Naomi Goldberg; Alex Sheldon; Samuel R Friedman; Hannah L F Cooper; Stephanie Beane; Leslie D Williams; Barbara Tempalski; Justin C Smith; Umedjon Ibragimov; Jonathan Mermin; Ron Stall
Journal:  J Acquir Immune Defic Syndr       Date:  2020-09-01       Impact factor: 3.771

5.  Inability to Work Fulltime, Prevalence and Associated Factors Among Applicants for Work Disability Benefit.

Authors:  Henk-Jan Boersema; Tialda Hoekstra; Femke Abma; Sandra Brouwer
Journal:  J Occup Rehabil       Date:  2021-03-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.